Skip to main content
OpenTrials
Completed

NCT Number: NCT06423196

Upper Limb Blood Flow Restriction in Handball Players

Introduction. Blood flow restriction therapy involves the use of an occlusion cuff placed over an extremity resulting in a partial reduction of arterial blood flow and total restriction of venous return.

Objectives. To analyse the efficacy of a physiotherapy intervention using blood flow restriction in improving upper limb strength in adult handball players.

Methods. Randomised, single-blind, clinical study. 20 athletes will be recruited and randomly assigned to the experimental and control groups. The intervention of the experimental group will consist of performing an exercise protocol after blood flow restriction. The intervention period will last 4 weeks, with a periodicity of 2 weekly sessions of 30 minutes each. The primary variable will be the strength of the triceps, epicondyle and epitrochlear musculature (pressure hand dynamometer). The secondary variable will be the muscle activation of this musculature (surface electromyography).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sports Physical Therapy

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Universidad Católica San Antonio, Murcia

Murcia, 30107, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Athletes over 18 years of age.
  • Federated in handball at the time of the study.
  • No lower limb injuries in the three months prior to the study.
  • Signing the informed consent document.

Exclusion criteria

  • Athletes who have undergone surgery in the year prior to the study.
  • People who do not attend at least 80% of the treatment sessions.
  • Players who are receiving physiotherapy treatment in parallel to the physical preparation of the team they are playing for.

Treatment and study plan

experimental group

Other

In the development of the exercises, the players will mobilise dumbbells of different weights that will be estimated according to the calculation of 30% of 1 RM. This workload with dumbbells is based on previous work where blood flow restriction was used in healthy athletes.

Primary outcomes

  1. Assess the muscle strength at screening visit

    Time frame: Screening visit, within the first seven days after treatment and after four weeks follow-up

    Muscle strength will be assessed with a pressure dynamometer (Lafayette Manual Muscle model). The strength of the triceps brachii, epicondyle and epitrochlear musculature will be measured. The evaluation protocol used by Morin et al. will be used. The unit of measurement is the Newton (the higher the value, the greater the muscle strength). The measurements are taken bilaterally. The mean value of the 2 measurements taken shall be used as a measure.

Secondary outcomes

  1. Assess the muscle activation at screening visit

    Time frame: Screening visit, within the first seven days after treatment and after four weeks follow-up

    Muscle activation will be measured by surface electromyography (model SHIMMMER2, Shimmer, Ireland). Electrode placement will be marked on standing subjects, and will be positioned according to European recommendations for the use of surface electromyography. A bipolar SEMG system will be used with circular electrodes of 10 mm diameter, 20 mm apart, placed longitudinally, in the direction of the muscle fibres under study, and with a reference electrode at a distance. The unit of measurement is µV, where the higher the score, the greater the muscle activation.

Sponsors and collaborators

Lead sponsor

Universidad Católica San Antonio de Murcia

Other

Registry information

Official study title

Efficacy of Upper Limb Blood Flow Restriction in Handball Players. Randomised Clinical Study

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
May 21, 2024
Registry last updated
Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.